Apimeds Pharmaceuticals US, Inc (APUS) Earnings History

Quarterly EPS Results — source: SEC EDGAR

Quarter	EPS Estimate	EPS Actual	Surprise	Result
Q22026 FY2026	—	$-11.77	—	Miss
Q12026 FY2026	—	$-2.26	—	Miss

Back to APUS overview · APUS holders · APUS KPIs

Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.